Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma

Published:2020-03 Issue:1 Volume:3 Page:1-11
ISSN:2096-5664
Container-title:Journal of Pancreatology
language:en
Short-container-title:

Author:

Leonhardt Carl S.,Traub Benno,Hackert Thilo,Klaiber Ulla,Strobel Oliver,Büchler Markus W.,Neoptolemos John P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference66 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Therapeutic developments in pancreatic cancer: current and future perspectives;Neoptolemos;Nat Rev Gastroenterol Hepatol,2018

4. Integrated genomic characterization of pancreatic ductal adenocarcinoma;Cancer Cell,2017

5. Real-time genomic profiling of pancreatic ductal adenocarcinoma: potential actionability and correlation with clinical phenotype;Lowery;Clin Cancer Res,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case Report on the Five-year Survival and Complete Response of a Patient with Pancreatic Cancer Treated with Integrative Medicine;The Journal of Internal Korean Medicine;2023-06-30

2. PRKRA promotes pancreatic cancer progression by upregulating MMP1 transcription via the NF-κB pathway;Heliyon;2023-06

3. Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05

4. GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma;Pancreatology;2022-09

5. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma;Frontiers in Immunology;2022-01-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3